Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2006 | 3 |
2007 | 1 |
2012 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Phase 1 Open-Label, Multicenter Study of First-in-Class RORγ Agonist LYC-55716 (Cintirorgon): Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.
Clin Cancer Res. 2019 Jun 15;25(12):3508-3516. doi: 10.1158/1078-0432.CCR-18-3185. Epub 2019 Feb 28.
Clin Cancer Res. 2019.
PMID: 30819679
Clinical Trial.
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.
Seiden MV, Gordon AN, Bodurka DC, Matulonis UA, Penson RT, Reed E, Alberts DS, Weems G, Cullen M, McGuire WP 3rd.
Seiden MV, et al. Among authors: weems g.
Gynecol Oncol. 2006 Apr;101(1):55-61. doi: 10.1016/j.ygyno.2005.09.036. Epub 2005 Nov 2.
Gynecol Oncol. 2006.
PMID: 16260029
Clinical Trial.
Item in Clipboard
Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy.
Kelly K, Azzoli CG, Zatloukal P, Albert I, Jiang PY, Bodkin D, Pereira JR, Juhász E, Iannotti NO, Weems G, Koutsoukos T, Patel JD.
Kelly K, et al. Among authors: weems g.
J Thorac Oncol. 2012 Jun;7(6):1041-8. doi: 10.1097/JTO.0b013e31824cc66c.
J Thorac Oncol. 2012.
PMID: 22534814
Free article.
Clinical Trial.
Item in Clipboard
A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors.
Hilgers W, Faivre S, Chieze S, Alexandre J, Lokiec F, Goldwasser F, Raymond E, Kahatt C, Taamma A, Weems G, MacDonald JR, Misset JL, Cvitkovic E.
Hilgers W, et al. Among authors: weems g.
Invest New Drugs. 2006 Jul;24(4):311-9. doi: 10.1007/s10637-005-5055-6.
Invest New Drugs. 2006.
PMID: 16683074
Clinical Trial.
Item in Clipboard
Pharmacokinetics, metabolism, and routes of excretion of intravenous irofulven in patients with advanced solid tumors.
Paci A, Rezai K, Deroussent A, De Valeriola D, Re M, Weill S, Cvitkovic E, Kahatt C, Shah A, Waters S, Weems G, Vassal G, Lokiec F.
Paci A, et al. Among authors: weems g.
Drug Metab Dispos. 2006 Nov;34(11):1918-26. doi: 10.1124/dmd.106.010512. Epub 2006 Aug 8.
Drug Metab Dispos. 2006.
PMID: 16896064
Clinical Trial.
Item in Clipboard
A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors.
Alexandre J, Kahatt C, Bertheault-Cvitkovic F, Faivre S, Shibata S, Hilgers W, Goldwasser F, Lokiec F, Raymond E, Weems G, Shah A, MacDonald JR, Cvitkovic E.
Alexandre J, et al. Among authors: weems g.
Invest New Drugs. 2007 Oct;25(5):453-62. doi: 10.1007/s10637-007-9071-6. Epub 2007 Jul 13.
Invest New Drugs. 2007.
PMID: 17628744
Clinical Trial.
Item in Clipboard
Cite
Cite